Diagnostic performance of specific biomarkers for interstitial lung disease: a single center study
KL-6 and SP-D levels are elevated in ILD and therefore contribute to the diagnosis and risk stratification for patient management.
Authors
- Sonia L. La’ulu
- Sogol Amjadi
- Troy D. Jaskowski
- Dorota Lebiedz‐Odrobina
- Tracy Frech (ORCID: https://orcid.org/0000-0002-5472-3840)
- Anne E. Tebo (ORCID: https://orcid.org/0000-0001-9553-298X)
- Anu S. Maharjan
Institutions
- University of Utah (US)
- ARUP Laboratories (United States) (US)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1515/cclm-2024-1048
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.42